Text Size

Impact of Asthma Treatments on Daily Activities

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2006 by Ovation Research Group.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Genentech
Information provided by:
Ovation Research Group
ClinicalTrials.gov Identifier:
NCT00350376
First received: July 5, 2006
Last updated: NA
Last verified: July 2006
History: No changes posted
  Purpose

The primary objective of this web-based, cross-sectional study is to assess and compare the ability to sleep, work or go to school, and to participate in leisure activities among subjects who are receiving Xolair treatment and subjects who were eligible to receive Xolair, but instead have been using Advair for at least 1 year.


Condition
Asthma
Allergies

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Cross-Sectional
Time Perspective: Retrospective
Official Title: Study on Asthma Treatments on Daily Activities as Reported by Patients (STAR)

Resource links provided by NLM:

MedlinePlus related topics: Allergy Asthma
U.S. FDA Resources

Further study details as provided by Ovation Research Group:

Estimated Enrollment: 1500
Study Start Date: June 2006
  Eligibility

Ages Eligible for Study:   18 Years to 55 Years
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Have asthma and allergies
  • Currently taking Xolair® or Advair®
  • Started Xolair® treatment within the last 4 to 12 months OR have been taking Advair® for at least 12 months
  • Between 18 and 55 years of age
  • A non-smoker for at least 6 months
  • Have internet access
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00350376

Contacts
Contact: Nita Ngo, MPH 888.631.9167 asthmastudy@ovation.org

Locations
United States, California
Ovation Research Group Recruiting
San Francisco, California, United States, 94105
Principal Investigator: Susan D Mathias, MPH            
Sponsors and Collaborators
Ovation Research Group
Genentech
Investigators
Principal Investigator: Susan D Mathias, MPH Ovation Research Group
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00350376     History of Changes
Other Study ID Numbers: 1467
Study First Received: July 5, 2006
Last Updated: July 5, 2006
Health Authority: United States: Institutional Review Board

Keywords provided by Ovation Research Group:
asthma
allergies
Xolair
Advair

Additional relevant MeSH terms:
Hypersensitivity
Asthma
Immune System Diseases
Bronchial Diseases
Respiratory Tract Diseases
 Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate

ClinicalTrials.gov processed this record on May 22, 2013